Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review

Saber, 2012, Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia, Blood, 119, 3908, 10.1182/blood-2011-09-381699 Appelbaum, 2008, Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available, Hematol Am Soc Hematol Educ Progr, 412, 10.1182/asheducation-2008.1.412 Gragert, 2014, HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry, N Engl J Med, 371, 339, 10.1056/NEJMsa1311707 Ciceri, 2008, A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation, Blood, 112, 3574, 10.1182/blood-2008-02-140095 Rizzieri, 2007, Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution, J Clin Oncol, 25, 690, 10.1200/JCO.2006.07.0953 Ciurea, 2010, Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT, Bone Marrow Transplant, 45, 429, 10.1038/bmt.2009.189 Luznik, 2001, Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide, Blood, 98, 3456, 10.1182/blood.V98.12.3456 O'Donnell, 2002, Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide, Biol Blood Marrow Transplant, 8, 377, 10.1053/bbmt.2002.v8.pm12171484 Ciurea, 2015, Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia, Blood, 126, 1033, 10.1182/blood-2015-04-639831 Di Stasi, 2014, Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors, Biol Blood Marrow Transplant, 20, 1975, 10.1016/j.bbmt.2014.08.013 Bashey, 2013, T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation, J Clin Oncol, 31, 1310, 10.1200/JCO.2012.44.3523 Raiola, 2014, Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts, Biol Blood Marrow Transplant, 20, 1573, 10.1016/j.bbmt.2014.05.029 Kanate, 2016, Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors, Blood, 127, 938, 10.1182/blood-2015-09-671834 Bashey, 2016, Biol Blood Marrow Transplant, 22, 125, 10.1016/j.bbmt.2015.09.002 Bacigalupo, 2009, Defining the intensity of conditioning regimens: working definitions, Biol Blood Marrow Transplant, 15, 1628, 10.1016/j.bbmt.2009.07.004 Sorror, 2005, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, 106, 2912, 10.1182/blood-2005-05-2004 Grimwade, 2010, Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials, Blood, 116, 354, 10.1182/blood-2009-11-254441 Martinelli, 1997, Early detection of bone marrow engraftment by amplification of hypervariable DNA regions, Haematologica, 82, 156 Rowlings, 1997, IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade, Br J Haematol, 97, 855, 10.1046/j.1365-2141.1997.1112925.x Jagasia, 2015, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. The 2014 Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 21, 389, 10.1016/j.bbmt.2014.12.001 Fine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, 94, 496, 10.1080/01621459.1999.10474144